We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERN
201
DELISTED
Cerner Corp
CERN
$13.7M 0.12%
174,878
+6,272
+4% +$483K
DEO icon
202
Diageo
DEO
$49.4B
$12.2M 0.11%
63,717
-13,175
-17% -$2.45M
HON icon
203
Honeywell
HON
$78.3B
$12.2M 0.11%
58,837
-16,360
-22% -$3.46M
BRKR icon
204
Bruker
BRKR
$9.58B
$12M 0.11%
158,210
-614,784
-80% -$42.9M
VSGX icon
205
Vanguard ESG International Stock ETF
VSGX
$6.42B
$12M 0.11%
186,880
+9,414
+5% +$601K
VWO icon
206
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$11.9M 0.11%
218,291
-38,652
-15% -$2.06M
TJX icon
207
TJX Companies
TJX
$178B
$11.8M 0.1%
174,518
+58,300
+50% +$3.97M
ZTS icon
208
Zoetis
ZTS
$32.5B
$11.7M 0.1%
62,829
+16,407
+35% +$2.85M
ORLY icon
209
O'Reilly Automotive
ORLY
$75.6B
$11.6M 0.1%
306,675
+119,025
+63% +$4.27M
EMR icon
210
Emerson Electric
EMR
$85B
$11.4M 0.1%
118,390
-1,021
-0.9% -$96K
MKC icon
211
McCormick & Company Non-Voting
MKC
$13.9B
$11.1M 0.1%
125,310
-11,200
-8% -$999K
CHKP icon
212
Check Point Software Technologies
CHKP
$14.1B
$10.7M 0.09%
91,922
-740
-0.8% -$87.3K
A icon
213
Agilent Technologies
A
$39.7B
$10.1M 0.09%
68,547
-53
-0.1% -$7.23K
XRAY icon
214
Dentsply Sirona
XRAY
$2.7B
$10.1M 0.09%
159,968
-42,950
-21% -$2.83M
EG icon
215
Everest Group
EG
$15.8B
$9.99M 0.09%
39,635
+10,990
+38% +$2.86M
CAC icon
216
Camden National
CAC
$979M
$9.66M 0.09%
202,327
-6,285
-3% -$299K
SNPS icon
217
Synopsys
SNPS
$73.5B
$9.06M 0.08%
32,850
+8,600
+35% +$2.18M
ZBH icon
218
Zimmer Biomet
ZBH
$18.5B
$8.9M 0.08%
57,011
+18,134
+47% +$2.94M
AVB icon
219
AvalonBay Communities
AVB
$27.2B
$8.65M 0.08%
41,445
+5,615
+16% +$1.12M
SNA icon
220
Snap-on
SNA
$21.7B
$8.45M 0.08%
37,815
+120
+0.3% +$28.7K
KMB icon
221
Kimberly-Clark
KMB
$37.5B
$8M 0.07%
59,765
+24,000
+67% +$3.2M
GABC icon
222
German American Bancorp
GABC
$1.92B
$7.76M 0.07%
208,683
-6,433
-3% -$270K
VOO icon
223
Vanguard S&P 500 ETF
VOO
$971B
$7.75M 0.07%
19,700
+1,299
+7% +$499K
H icon
224
Hyatt Hotels
H
$17.8B
$7.32M 0.07%
94,300
-1,950
-2% -$158K
LH icon
225
Labcorp
LH
$25.8B
$6.43M 0.06%
27,127
+10,918
+67% +$2.49M

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.